[00:08] fitness supplement for building muscle and improving athletic recovery. Over the past few years, scientific interest has expanded towards organs with intense energy demands, particularly the brain and immune system. In 2024,
[00:22] neuroscientists published a human clinical trial testing whether a single large dose of creatin could preserve brain bioenergetics during severe sleep loss. In cancer immunology, preclinical work
[00:35] shows that killer tea cells rely on creatin uptake to fuel their cytotoxic response against tumor cells. These discoveries have prompted widespread speculation about whether higher creatin doses can protect cognitive function and
[00:50] doses can protect cognitive function and immune vitality as we age. To evaluate these claims, we need to look at how cells manage energy under stress. Skeletal muscle holds roughly 95% of the body's total creatin pool. Because
[01:04] muscle represents such a large share of physical mass, sports science spent three decades optimizing daily doses around 3 to 5 gram to saturate muscle fibers. Other tissues operate under very
[01:18] different metabolic constraints. The human brain accounts for roughly 2% of the body weight, yet it consumes over 20% of resting metabolic energy. Neurons maintain constant electrical signaling and iron pumping, requiring an
[01:34] uninterrupted supply of adenosine triphosphate or ATP. Immune cells face similar energetic surges. When cytotoxic killer tea cells encounter an infected abnormal cell, they mobilize cellular machinery to
[01:50] deliver a targeted attack within minutes. In both systems, creatine functions like a rechargeable battery pack sitting alongside primary cellular engine. Cellular mitochondria produce ATP continuously. When acute demands
[02:05] exceed immediate mitochondrial output, the phosphocreatin system steps in transferring a high energy phosphate group to regenerate ATP within milliseconds. The central question of for health span is whether oral creatine
[02:19] supplements effectively reach these non-muscle tissues and what clinical humans. In 2024, a research team led by Ali
[02:31] Gorge Nad at Forjong Centum Julich and RWTH Aren University in Germany published a double blind randomized placeboc controlled crossover trial in placeboc controlled crossover trial in scientific reports. The trial involved
[02:45] 15 healthy young adults aged 20 to 28. The researchers subjected these participants to 21 hours of continuous monitored sleep deprivation while monitored sleep deprivation while administering demanding cognitive tests.
[02:59] This protocol tested acute energetic exhaustion. It is a model of temporary metabolic fatigue in healthy young brains distinct from chronic neuro degeneration or age related cognitive decline. Participants received either a
[03:14] placebo or a single high dose of creatin monohydrate at.35 grams per kilogram of body weight. For an average adult, that represents a single bolus of 25 to 30 gram. The researchers used magnetic resonance
[03:29] spectroscopy to evaluate brain chemistry across four scanning sessions throughout the night. The cognitive data showed clear differences between the two nights. Compared to placebo, participants on creatin scored
[03:43] approximately 10% higher on a word pair memory test. They also processed language, logic, and numeric tasks faster. Subjective exhaustion rose by roughly 145% on the creatin light compared to 172% on
[03:59] on the creatin light compared to 172% on the placebo reflecting a modest 8% reduction in subjective fatigue during the early morning hours. Participants were still exhausted. The supplement buffered specific cognitive
[04:13] processing speed and memory retrieval under acute metabolic strain. The spectroscopy scans provided biological insights into this performance buffer. Sustained sleep loss typically causes a drop in cerebral
[04:27] phosphocreatin relative to inorganic phosphate alongside a drop in brain pH. The highdosese creatin bolus stabilized brain pH and preserved the phosphocreatin to inorganic phosphate
[04:41] ratio. Interestingly, free ATP levels as measured via beta ATP dipped slightly. The researchers explained this isn't an energy drop, but rather the brain actively using up some free ATP to charge the newly available creatine into
[04:57] phosphocreatin reserves. Measurable effects emerged around 3 and 1/2 hours after ingestion and persisted through the final measurement at 9 hours. This study demonstrate that a large oral bolus can influence brain bioenergetics
[05:12] bolus can influence brain bioenergetics during severe acute fatigue. Translating that observation into a daily longevity habit reveals significant physiological complexities. A primary barrier to brain creatine
[05:25] uptake is the bloodb brain barrier. Unlike skeletal muscle which expresses abundant SLC68 creatin transporters on its cell membranes, the endothelial cells lining brain capillaries express limited
[05:39] transporter density. Furthermore, the central nervous system synthesizes most of its creatine endogenously. Astroytes and neurons produce creatine locally, tightly regulating central pores and restricting influx from the
[05:54] The researchers in the German sleep trial noted that severe sleep deprivation might temporarily alter transporter dynamics or cerebral metabolism, allowing acute uptake that might not occur under well-rested
[06:08] conditions. When we examine chronic daily supplementation in humans, the data reveals a clear physiological pattern governed by baseline energetic demand. In a 2021 review published in in
[06:22] nutrients, Dr. Hamilton Rashel and colleagues evaluated the literature on creatine and brain health. Across 12 magnetic resonance spectroscopy studies, nine observed modest increases in brain creatin, typically between 5 to 10%.
[06:38] That represents roughly half the relative accumulation typically seen in skeletal muscle. Several studies such as a 2017 trial by Solis colleagues using 25 grams daily for 7 days found no measurable uptake. This variability in
[06:55] brain uptake directly mirrors cognitive performance outcomes in healthy well-rested young omnivores. Supplemental creatine rarely produces Supplemental creatine rarely produces measurable cognitive gains. A 2023 study
[07:10] by Moriati and colleagues evaluated daily doses of 10 and 20 grams over 6 weeks in young adults and found no changes in cognitive performance or prefrontal brain activation. In these individuals, baseline cerebral
[07:25] creatin levels and resting mitochondrial output already meet cognitive demands. Measurable benefits emerge primarily when the brain faces an energetic deficit, particularly during aging. As the brain ages, mitochondrial
[07:41] efficiency diminishes and endogenous creatin synthesis declines. Under these conditions, oral supplementation demonstrates measurable clinical effects. In a double blind placeboc control trial by Mc Morris and
[07:56] colleagues, 32 older adults with an average age of 76 received 20 grams of average age of 76 received 20 grams of creatine monohydrate daily for 7 days. Supplementation produced statistically significant improvements in long-term
[08:09] memory forward digital recall and spatial recall. This age divergence was confirmed in a 2023 systemic review and metaanalysis published in nutrition reviews by Dr. Constantinos
[08:23] Procoidis and colleagues evaluating randomized control trials across different age brackets. The metro analysis found no significant memory benefits in younger adults age 11 to 31. In contrast, older adults aged 66 to 76
[08:39] demonstrated a robust, statistically significant improvement in memory performance. Researchers are now evaluating whether this metabolic buffer extends to clinical cognitive impairment.
[08:52] Observational brain imaging shows that during the transition from mild cognitive impairment to dementia, cerebral concentrations of creatin and anacetylpartate steadily decline reflecting progressing
[09:06] bioenergetic failure. In 2025, researchers at the University of Kansas Medical Center led by Dr. Matthew Taylor published a pilot clinical trial in the journal Alzheimer's and Dementia. The team administered 20 grams of creatine
[09:21] monohydrate daily for 8 weeks to 19 older adults diagnosed with Alzheimer's disease. Brain imaging showed an 11% increase in total brain creatin levels
[09:33] accompanied by measurable improvements in working memory and executive function tests. For more details, please see our talk with Dr. Taylor about this study which I have linked to above. However, critical clinical caveats
[09:48] apply. The cancer study was an openleabel pilot with only 19 participants and lacked a placebo control group. While it demonstrates that highdose creatine can cross into the brain and support cellular
[10:01] bioenergetics in older adults, it does not prove long-term disease modification. Furthermore, when researchers evaluated long-term highdose creatine in large rigorous clinical trials for
[10:15] neurodeenerative conditions such as net PD trials in Parkinson's disease and the Crest E trial in Huntington's disease, creatin failed to slow structural disease progression. Creatin functions as a metabolic battery
[10:30] that supports energetic throughput in vulnerable or aging neurons. It provides acute energetic support but does not reverse underlying neurodeenerative pathology. While neuroscientists examine cerebral
[10:44] metabolism, immunologists have uncovered a parallel role of creatin in immune a parallel role of creatin in immune defense. In 2019, a research team led by defense. In 2019, a research team led by Dr. Lily Yang at UCLA published a study
[10:57] in the Journal of Experimental Medicine examining how cytotoxic CD8 tea cells fuel their response against tumor cells. Cytotoxic tea cells identify and destroy infected or abnormal cells. When these
[11:12] killer tea cells become activated, they dramatically increase the expression of their creatin transporter gene, absorbing creatine from the immediate surroundings. Targeting an abnormal cell requires substantial localized energy.
[11:27] When a killer tea cell binds to its target, it forms an immunological sinapse and releases specialized cytotoxic proteins to destroy the target cell. Delivering those proteins requires an immediate localized pulse of ATP.
[11:42] Creatin serves as an ondemand energy buffer directly at the contact site. To test this mechanism, the UCLA researchers engineered mice lacking the creatin transporter gene. These knockout mice developed normal baseline immune
[11:58] systems. But when challenged with a melanoma, the killer tea cells displayed impaired control leading to accelerated tumor growth compared to normal litamates. The researchers then tested creatin
[12:11] supplementation in mice with intact transporters. Oral creatin supplementation slowed tumor growth in a colon cancer model known to respond to colon cancer model known to respond to immunotherapy. Combining creatin with an
[12:24] antiPD1 checkpoint inhibitor, a drug that cuts the molecular breaks cancers use to hide from TE-C cells, allow four out of five mice to clear their tumors in a small experimental group. These preclinical findings provide valuable
[12:39] proof of concepts for immuno metabolism. However, their translational boundaries require clear distinction. This work was conducted entirely in mice and mouse immune cells challenged with rapid tumor models where immune cells actively
[12:54] compete with cancer cells for nutrients. The combination has not been evaluated in human clinical trials and the study did not examine age- related immune decline or general infection defense in older adults. Taking creatin to enhance
[13:09] immune longevity or support cancer defense in humans remains an untested Understanding these scientific boundaries helps establish a grounded approach to supplementation and lab monitoring.
[13:23] First, consider daily dosing. The sleep deprivation study used a single active bolus of 25 to 30 grams. Some specialized psychiatric studies have explored 10 grams daily. However, there is no clinical consensus or validated
[13:40] trial establishing 10 grams per day as a longevity protocol for brain or immune health. For healthy adults, 3 to 5 grams of standard creatine monohydrate per day remains the thoroughly validated baseline for muscle function, cellular
[13:55] hydration, and general metabolic support. Higher intakes remain exploratory. If you choose to use higher doses, split the intake into morning and afternoon servings of five grams each to reduce
[14:09] digestive discomfort. Second, consider gastrointestinal tolerability. Creatin monohydrate dissolves slowly in cold water. Undissolved crystals entering the digestive tract can draw water into the
[14:23] intestinal lumen, causing cramps or loose stool. Dissolving your daily dose in warm water, tea, or broth allows the powder to fully dissolve within 30 seconds, significantly reducing digestive irritation.
[14:37] Third, every adult taking creatin must understand a common laboratory blood test artifact. Serum creatinin versus true kidney function. Creatine naturally degrades at a steady daily rate into creatinine, a
[14:53] benign metabolic byproduct cleared by the kidneys. Standard metabolic panels measure serum creatinine to calculate your estimated glomelular filtration rate or EGFR. When you supplement creatin, your serum
[15:09] creatinine levels typically rise, which causes your calculated EGFR to drop on paper. A physician unfamiliar with your supplement intake may express concern about early kidney dysfunction based purely on that elevated creatinin
[15:24] reading. If your kidney numbers appear abnormal after starting creatin, inform your doctor that you supplement with creatin monohydrate. To obtain an accurate assessment, your physician can order a cyatin C blood test. Cyatin C is
[15:40] a filtration marker produced by nucleiated cells throughout the body. Its levels are far less dependent on dietary creatin intake or muscle mass than creatinin. Though factors like thyroid function or systemic
[15:53] inflammation can still influence readings. While creatin is a well established as safe for individuals with healthy kidneys at standard doses, anyone with pre-existing renal disease, diabetes, or
[16:06] those taking nephrotoxic medication should always consult their physician before supplementing. Regarding product selection, stick with pure micronized creatine monohydrate.
[16:19] Expensive marketing variants such as creatine ethyl estester buffered creatin or liquid formulations have consistently failed to demonstrate superior absorption or efficacy in independent clinical trials. Creatin is an essential
[16:33] bioenergetic buffer that supports cellular resilience far beyond skeletal muscle. In the brain, a single highdosese bolus buffered cerebral high energy phosphates and improved processing speed and memory by roughly
[16:47] 10% in young adults during 21 hours of severe sleep deprivation. However, chronic supplementation protocols for long-term brain health remain unresolved and large trials in neurodeenerative conditions were negative. in the immune
[17:02] system. Preclinical mouse studies show that killer tea cells rely on creatin to fuel localized attacks on tumor cells. Whether this mechanism influences human immune aging remains unstudied in clinical trials. Thank you for watching
[17:18] Modern Healthspan. Please hit the like, share your thoughts in the comments, and subscribe for more evidence-based longevity reporting.